Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment

First annual Harvard FUSION symposium assembles leaders at the convergence of science and business

Six outstanding HBS alumni will work with inventors from the Harvard community, advance commercialization of life-science technologies

Harvard chemists hope to shorten time and difficulty in measuring effectiveness and potential of new compounds